• Home>
  • Stocks>
  • Healthcare Global Enterprises Ltd Share Price
Healthcare Global Enterprises Ltd share price logo

Healthcare Global Enterprises Ltd Share Price

(HCG)

₹575.550.01%

as on 04:01PM, 23 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Healthcare Global Enterprises Ltd Performance

  • Day's Low

    Day's High

    ₹566.05
    Day's Price Range
    ₹583.85
  • 52 Week's Low

    52 Week's High

    ₹330.65
    52-Week Price Range
    ₹601.95
1 Month Return+ 5.71 %
3 Month Return+ 11.73 %
1 Year Return+ 58.67 %
Previous Close₹575.50
Open₹577.00
Volume3.12L
Upper Circuit₹690.60
Lower Circuit₹460.40
Market Cap₹8,023.35Cr

Healthcare Global Enterprises Ltd Fundamentals

P/E Ratio

137.35

PEG Ratio

82.74

Market Cap

₹8,023.35 Cr

P/B Ratio

3.96

EPS

2.97

Dividend Yield

0

Sector

Healthcare

ROE

3.22

Healthcare Global Enterprises Ltd Analyst Rating

based on 8 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 8 analysts offering long term price targets for Healthcare Global Enterprises Ltd. An average target of ₹526.25

Source: S&P Global Market Intelligence

Healthcare Global Enterprises Ltd Share analysis

Healthcare Global Enterprises Ltd price forecast by 8 analysts

Downside of-8.56%

High

₹621

Target

₹526.25

Low

₹342

Healthcare Global Enterprises Ltd target price ₹526.25, a slight downside of -8.56% compared to current price of ₹575.55. According to 8 analysts rating.

Source: S&P Global Market Intelligence

Key events for Healthcare Global Enterprises Ltd

  • HCG Expands Largest Private Oncology Facility in Gujarat - 21 Apr, 2025

    HealthCare Global Enterprises Ltd (HCG) has inaugurated the expanded HCG Aastha Cancer Centre in Ahmedabad, now the largest private oncology facility in Gujarat, featuring a 217-bed capacity and advanced cancer care technologies. The expansion aims to enhance access to high-quality cancer treatment for patients in the region.
  • KKR to Become Largest Shareholder in HCG - 16 Apr, 2025

    On February 23, 2025, KKR announced a deal to acquire up to 54% equity in Healthcare Global Enterprises Ltd (HCG) from CVC at ₹445 per share, with plans to purchase additional shares from public shareholders. This transaction will position KKR as the largest shareholder, controlling between 54-77% of HCG's operations.
  • HCG Stock Poised for Breakout - 24 Mar, 2025

    Healthcare Global Enterprises Ltd (HCG) is on the verge of breaking out from consolidation, trading near its 52-week high. Key indicators like RSI and MACD suggest a sustainable uptrend, with the stock forming higher tops and bottoms on the daily chart. Target price is set at Rs. 578.625 with a stop-loss at Rs. 481.

Insights on Healthcare Global Enterprises Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, HCG has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 13.06% to 13.86% in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Max Healthcare Institute Ltd has given 172.4% return, outperforming this stock by 74.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 564.67 Cr → 564.11 Cr (in ₹), with an average decrease of 0.1% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 71.23% to 71.22% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, HCG stock has moved down by -2.9%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.77% to 2.45% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 10.04% to 9.19% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 17.99 Cr → 6.98 Cr (in ₹), with an average decrease of 61.2% per quarter

Healthcare Global Enterprises Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹468.95Cr (-)₹493.25Cr (↑5.18%)₹524.69Cr (↑6.37%)₹552.47Cr (↑5.29%)₹557.55Cr (↑0.92%)
Net Income₹3.43Cr (-)₹23.46Cr (↑583.97%)₹13.63Cr (↓41.90%)₹20.68Cr (↑51.72%)₹7.75Cr (↓62.52%)
Net Profit Margin0.73% (-)4.76% (↑552.05%)2.60% (↓45.38%)3.74% (↑43.85%)1.39% (↓62.83%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,655.87Cr (-)₹1,722.91Cr (↑4.05%)₹1,815.94Cr (↑5.40%)₹2,297.46Cr (↑26.52%)
Total Liabilities₹732.08Cr (-)₹625.22Cr (↓14.60%)₹670.81Cr (↑7.29%)₹1,108.87Cr (↑65.30%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹86.34Cr (-)₹70.89Cr (↓17.89%)₹124.40Cr (↑75.48%)₹130.40Cr (↑4.82%)₹194.71Cr (↑49.32%)

Healthcare Global Enterprises Ltd Index Inclusions

BSE Healthcare

₹42,693.01

0.96 (407.96%)

BSE Small-Cap

₹49,272.64

0.26 (129.52%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Healthcare Global Enterprises Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
71.22%
0.00
Foreign Institutions
2.45%
0.00
Mutual Funds
9.19%
0.00
Retail Investors
13.86%
0.00
Others
3.29%
0.00

Healthcare Global Enterprises Ltd Key Indicators

Details20202021202220232024
Earning Per Share (₹)-14.14-17.642.81.272.97
Details202220232024
Return On Equity %1.193.073.22
Details20202021202220232024
Return On Assets %-5.8-11.683.121.622.1
Details20202021202220232024
Book Value Per Share (₹)42.9952.1162.6161.8659.28

Healthcare Global Enterprises Ltd Valuation

Healthcare Global Enterprises Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-514.24x)

November 27, 2018

Industry (102.60x)

April 22, 2025

Today (137.35x)

April 22, 2025

Highest (201.31x)

July 2, 2018

LowHigh

Healthcare Global Enterprises Ltd Earnings and Dividends

  • Healthcare Global Enterprises Ltd Earnings Results

    Healthcare Global Enterprises Ltd’s net profit jumped 22.46% since last year same period to ₹6.98Cr in the Q3 2024-2025. On a quarterly growth basis, Healthcare Global Enterprises Ltd has generated -61.2% fall in its net profits since last 3-months.

    Read More about Earnings Results

Healthcare Global Enterprises Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Healthcare Global Enterprises Ltd is currently in a Bullish trading position according to technical analysis indicators.

Healthcare Global Enterprises Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹8,023.35 Cr140.08%0.70₹41 Cr₹1,907 Cr
HOLD₹23,088.87 Cr17.11%0.55₹362 Cr₹2,226 Cr
BUY₹8,988.04 Cr8.78%0.58₹128 Cr₹1,207 Cr
NA₹2,822.31 Cr51.6%0.50-₹106 Cr₹11 Cr
BUY₹3,955.40 Cr350.7%0.71₹49 Cr₹878 Cr

About Healthcare Global Enterprises Ltd

Healthcare Global Enterprises Ltd (HCG) is a leading provider of specialty healthcare services in India, focused on cancer and fertility. With 18 comprehensive cancer centres and 7 fertility centres across India, HCG operates two multispeciality hospitals in Ahmedabad and Bhavnagar with 118 and 39 operational beds respectively, and its key specialties include cardiology, neurology, orthopaedics, and urology. It also provides clinical reference laboratory services in India under the Triesta brand specialising in oncology, and research and development services to pharmaceutical and biotechnology companies.

Established in 1998, HCG expanded its operations in 2016 with a successful Initial Public Offering (IPO) and launched advanced cancer centres in Baroda and Visakhapatnam. Later, in 2017, it acquired a majority stake in Cancer Care Kenya, and launched its first cancer centre in Kanpur with 90 dedicated beds. It is also setting up hospitals with high end linear accelerators in Kolkata and Nashik. HCG has been dedicated to delivering quality medical care across diagnosis and treatment, and its latest technologies like Robotic Surgery and Tomotherapy Treatment System are paving the way for a better tomorrow.

Revenue: ₹557.55Cr as on December 2024 (Q4 24)
Net Profit: ₹7.75Cr as on December 2024 (Q4 24)
Listing date: 30 Mar, 2016
Chairperson Name: BASAVALINGA AJAIKUMAR SADASHIVAIAH
OrganisationHealthcare Global Enterprises Ltd
HeadquartersBengaluru
IndustryHealthcare
E-voting on sharesClick here to vote

FAQs on Healthcare Global Enterprises Ltd

What is Healthcare Global Enterprises Ltd price today?

Healthcare Global Enterprises Ltd share price today stands at ₹575.55, Open: ₹577, Previous Close: ₹575.5, High: ₹583.85, Low: ₹566.05, 52 Week High: ₹601.95, 52 Week Low: ₹330.65.

How to Buy Healthcare Global Enterprises Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Healthcare Global Enterprises Ltd shares

What are today's traded volumes of Healthcare Global Enterprises Ltd?

Today's traded volume of Healthcare Global Enterprises Ltd(HCG) is 3.12L.

What is today's market capitalisation of Healthcare Global Enterprises Ltd?

Today's market capitalisation of Healthcare Global Enterprises Ltd(HCG) is ₹8023.35Cr.

What is the 52 Week High and Low Range of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd (HCG)
Price
52 Week High
₹601.95
52 Week Low
₹330.65

How much percentage Healthcare Global Enterprises Ltd is down from its 52 Week High?

Healthcare Global Enterprises Ltd (HCG) share price is ₹575.55. It is down -4.39% from its 52 Week High price of ₹601.95

How much percentage Healthcare Global Enterprises Ltd is up from its 52 Week low?

Healthcare Global Enterprises Ltd (HCG) share price is ₹575.55. It is up 74.07% from its 52 Week Low price of ₹330.65